141 related articles for article (PubMed ID: 17128101)
1. [Functional scales and motor assessment in amyotrophic lateral sclerosis].
Benaïm C; Desnuelle C; Fournier-Méhouas M
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S131-4S137. PubMed ID: 17128101
[TBL] [Abstract][Full Text] [Related]
2. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
3. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
[TBL] [Abstract][Full Text] [Related]
4. Outcome measures for early phase clinical trials.
Gordon PH; Cheng B; Montes J; Doorish C; Albert SM; Mitsumoto H
Amyotroph Lateral Scler; 2007 Oct; 8(5):270-3. PubMed ID: 17852017
[TBL] [Abstract][Full Text] [Related]
5. Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis.
de Carvalho M; Scotto M; Lopes A; Swash M
Muscle Nerve; 2003 Nov; 28(5):630-3. PubMed ID: 14571468
[TBL] [Abstract][Full Text] [Related]
6. Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial.
Kaufmann P; Levy G; Montes J; Buchsbaum R; Barsdorf AI; Battista V; Arbing R; Gordon PH; Mitsumoto H; Levin B; Thompson JL;
Amyotroph Lateral Scler; 2007 Feb; 8(1):42-6. PubMed ID: 17364435
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of strength in amyotrophic lateral sclerosis].
Campana-Salort E
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S138-4S144. PubMed ID: 17128102
[TBL] [Abstract][Full Text] [Related]
8. ALSFRS and appel ALS scores: discordance with disease progression.
Voustianiouk A; Seidel G; Panchal J; Sivak M; Czaplinski A; Yen A; Appel SH; Lange DJ
Muscle Nerve; 2008 May; 37(5):668-72. PubMed ID: 18288708
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance in the change of decline in ALSFRS-R.
Castrillo-Viguera C; Grasso DL; Simpson E; Shefner J; Cudkowicz ME
Amyotroph Lateral Scler; 2010; 11(1-2):178-80. PubMed ID: 19634063
[TBL] [Abstract][Full Text] [Related]
10. Natural history of amyotrophic lateral sclerosis. Observations with the Charing Cross Amyotrophic Lateral Sclerosis Rating Scales.
Guiloff RJ; Goonetilleke A
Adv Neurol; 1995; 68():185-98. PubMed ID: 8787229
[TBL] [Abstract][Full Text] [Related]
11. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
Kimura F; Fujimura C; Ishida S; Nakajima H; Furutama D; Uehara H; Shinoda K; Sugino M; Hanafusa T
Neurology; 2006 Jan; 66(2):265-7. PubMed ID: 16434671
[TBL] [Abstract][Full Text] [Related]
12. Cross-sectional and longitudinal correlations between disease progression and different health-related quality of life domains in persons with amyotrophic lateral sclerosis.
De Groot IJ; Post MW; van Heuveln T; Van den Berg LH; Lindeman E
Amyotroph Lateral Scler; 2007 Dec; 8(6):356-61. PubMed ID: 18033593
[TBL] [Abstract][Full Text] [Related]
13. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
[TBL] [Abstract][Full Text] [Related]
14. Maximum voluntary isometric contraction: reference values and clinical application.
Meldrum D; Cahalane E; Conroy R; Fitzgerald D; Hardiman O
Amyotroph Lateral Scler; 2007 Feb; 8(1):47-55. PubMed ID: 17364436
[TBL] [Abstract][Full Text] [Related]
15. Validity of the Dutch version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire, ALSAQ-40, ALSAQ-5.
Maessen M; Post MW; Maillé R; Lindeman E; Mooij R; Veldink JH; van den Berg LH
Amyotroph Lateral Scler; 2007 Apr; 8(2):96-100. PubMed ID: 17453637
[TBL] [Abstract][Full Text] [Related]
16. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience.
Appel V; Stewart SS; Smith G; Appel SH
Ann Neurol; 1987 Sep; 22(3):328-33. PubMed ID: 3118763
[TBL] [Abstract][Full Text] [Related]
17. Motor responses of the sternocleidomastoid muscle in patients with amyotrophic lateral sclerosis.
Pinto S; de Carvalho M
Muscle Nerve; 2008 Oct; 38(4):1312-7. PubMed ID: 18785186
[TBL] [Abstract][Full Text] [Related]
18. Use of electrophysiologic tests to measure disease progression in ALS therapeutic trials.
Kelly JJ; Thibodeau L; Andres PL; Finison LJ
Muscle Nerve; 1990 Jun; 13(6):471-9. PubMed ID: 2195338
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation.
Iwata NK; Aoki S; Okabe S; Arai N; Terao Y; Kwak S; Abe O; Kanazawa I; Tsuji S; Ugawa Y
Neurology; 2008 Feb; 70(7):528-32. PubMed ID: 18268244
[TBL] [Abstract][Full Text] [Related]
20. ALSFRS-R.
Gordon PH; Miller RG; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():90-3. PubMed ID: 15512883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
